Literature DB >> 15294050

Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus.

E E Blaak1.   

Abstract

The present article addresses the hypothesis that disturbances in skeletal muscle fatty acid handling in abdominal obesity and type 2 diabetes mellitus may play a role in the aetiology of increased adipose tissue stores, increased triacylglycerol storage in skeletal muscle and skeletal muscle insulin resistance. The uptake and/or oxidation of fatty acids have been shown to be impaired during post-absorptive conditions in abdominally-obese subjects and/or subjects with type 2 diabetes. Also, human studies have shown that muscle of subjects that are (abdominally) obese and/or have type 2 diabetes is characterized by an inability to increase fatty acid uptake and/or fatty acid oxidation during beta-adrenergic stimulation and exercise. This disturbance in fat oxidation may promote, on one hand, the development of increased adipose tissue stores and obesity. On the other hand, fatty acids that are taken up by muscle and not oxidized may increase triacylglycerol storage in muscle, which has been associated with skeletal-muscle insulin resistance. Disturbances in the capacity to increase fat oxidation during post-absorptive conditions, beta-adrenergic stimulation and exercise in subjects who are obese and/or have type 2 diabetes persist after weight reduction, indicating that the diminished fat oxidation may be a primary factor leading to the obese and/or insulin-resistant state rather than an adaptational response. Clearly, the precise sequence of events leading to an increased adiposity and insulin resistance in obesity and type 2 diabetes mellitus is not yet fully understood.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15294050     DOI: 10.1079/PNS2004361

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  24 in total

1.  Fighting obesity: When muscle meets fat.

Authors:  Xin Yang; Pengpeng Bi; Shihuan Kuang
Journal:  Adipocyte       Date:  2014-12-10       Impact factor: 4.534

2.  The nuclear receptor, Nor-1, markedly increases type II oxidative muscle fibers and resistance to fatigue.

Authors:  Michael A Pearen; Natalie A Eriksson; Rebecca L Fitzsimmons; Joel M Goode; Nick Martel; Sofianos Andrikopoulos; George E O Muscat
Journal:  Mol Endocrinol       Date:  2012-01-26

3.  Congenital and environmental factors associated with adipocyte dysregulation as defects of insulin resistance.

Authors:  Chao-Ping Wang; Fu-Mei Chung; Shyi-Jang Shin; Yau-Jiunn Lee
Journal:  Rev Diabet Stud       Date:  2007-08-10

Review 4.  Perspective: A Historical and Scientific Perspective of Sugar and Its Relation with Obesity and Diabetes.

Authors:  Richard J Johnson; Laura G Sánchez-Lozada; Peter Andrews; Miguel A Lanaspa
Journal:  Adv Nutr       Date:  2017-05-15       Impact factor: 8.701

5.  Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study.

Authors:  E Corpeleijn; E J M Feskens; E H J M Jansen; M Mensink; W H M Saris; T W A de Bruin; E E Blaak
Journal:  Diabetologia       Date:  2006-08-03       Impact factor: 10.122

6.  Peroxisome proliferator-activated receptor γ decouples fatty acid uptake from lipid inhibition of insulin signaling in skeletal muscle.

Authors:  Shanming Hu; Jianrong Yao; Alexander A Howe; Brandon M Menke; William I Sivitz; Arthur A Spector; Andrew W Norris
Journal:  Mol Endocrinol       Date:  2012-04-03

7.  Human genome comparison of paretic and nonparetic vastus lateralis muscle in patients with hemiparetic stroke.

Authors:  Michael J McKenzie; Shuzhen Yu; Richard F Macko; John C McLenithan; Charlene E Hafer-Macko
Journal:  J Rehabil Res Dev       Date:  2008

8.  Transgenic muscle-specific Nor-1 expression regulates multiple pathways that effect adiposity, metabolism, and endurance.

Authors:  Michael A Pearen; Joel M Goode; Rebecca L Fitzsimmons; Natalie A Eriksson; Gethin P Thomas; Gary J Cowin; S-C Mary Wang; Zewen K Tuong; George E O Muscat
Journal:  Mol Endocrinol       Date:  2013-09-24

9.  Metabolic profiling of PPARalpha-/- mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation.

Authors:  Liza Makowski; Robert C Noland; Timothy R Koves; Weibing Xing; Olga R Ilkayeva; Michael J Muehlbauer; Robert D Stevens; Deborah M Muoio
Journal:  FASEB J       Date:  2008-10-22       Impact factor: 5.191

10.  Glucometabolic consequences of acute and prolonged inhibition of fatty acid oxidation.

Authors:  Anne-Marie Lundsgaard; Andreas M Fritzen; Trine S Nicolaisen; Christian S Carl; Kim A Sjøberg; Steffen H Raun; Anders B Klein; Eva Sanchez-Quant; Jakob Langer; Cathrine Ørskov; Christoffer Clemmensen; Matthias H Tschöp; Erik A Richter; Bente Kiens; Maximilian Kleinert
Journal:  J Lipid Res       Date:  2019-11-12       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.